Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",21833,195,1.37 [0.98-1.90],0.0632861628249589
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23046,252,1.47 [1.10-1.96],0.0082879395924007
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22771,1752,1.44 [1.29-1.61],6.940469567186652e-11
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Candidiasis,23052,551,1.30 [1.07-1.59],0.0079593544841338
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22294,4233,1.24 [1.15-1.33],6.112662348852728e-09
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22240,4315,1.34 [1.25-1.44],3.5047255500306806e-16
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,22756,1428,1.28 [1.14-1.45],6.471907093998962e-05
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,22953,130,1.98 [1.34-2.92],0.0006320972857848
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,20228,1302,1.40 [1.23-1.59],3.83142800711877e-07
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19517,1585,1.58 [1.41-1.78],1.2061693619403415e-14
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,19010,341,1.84 [1.43-2.37],2.245922965809412e-06
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14976,2750,1.32 [1.21-1.45],6.726867117286706e-10
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,18944,495,1.59 [1.28-1.96],1.789894142816028e-05
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23028,1700,1.30 [1.17-1.46],3.423002006179623e-06
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Mycoses,23147,646,1.34 [1.12-1.61],0.0013775724190448
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22263,1244,1.53 [1.34-1.74],1.2549810437361044e-10
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23075,1437,1.33 [1.18-1.50],3.4170264573996697e-06
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21580,252,1.51 [1.13-2.02],0.005238568831699
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23207,67,1.13 [0.64-2.00],0.6782751484366496
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22892,1254,1.33 [1.17-1.51],1.642977796015702e-05
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,22904,81,1.09 [0.65-1.81],0.7443800304770539
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23142,144,1.25 [0.85-1.84],0.2512409682303794
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23120,122,1.23 [0.81-1.87],0.3257502866554345
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21515,496,1.79 [1.46-2.19],2.1484153337973585e-08
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,21326,307,1.43 [1.10-1.87],0.0077920430038826
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,21467,139,1.89 [1.29-2.77],0.0010833894043191
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23192,51,2.06 [1.11-3.81],0.0214070196506625
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23138,176,1.00 [0.70-1.42],0.9942537213548458
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Viral warts,23018,56,0.92 [0.49-1.73],0.8067005359098258
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23043,81,1.07 [0.64-1.79],0.7905219110735253
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign lipomatous neoplasm,22913,267,0.96 [0.72-1.28],0.7702670779926908
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23124,39,1.21 [0.57-2.55],0.6158456246717767
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23107,44,1.25 [0.63-2.50],0.5277499548681541
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,11060,86,1.17 [0.71-1.92],0.5487809646137121
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22740,1680,0.90 [0.80-1.01],0.0618313446640145
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign neoplasm of meninges,23191,64,1.49 [0.84-2.67],0.1738196064902303
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23111,78,1.47 [0.87-2.46],0.1468631694736755
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23179,120,1.20 [0.79-1.83],0.3927880241687386
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign neoplasm of ovary,12076,80,0.92 [0.54-1.56],0.7575426665038327
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23168,446,0.85 [0.68-1.06],0.1415675448167891
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign neoplasm: Caecum,23173,387,0.79 [0.62-1.00],0.0541837140679338
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23058,86,0.97 [0.59-1.60],0.9120507071501068
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign neoplasm: Descending colon,23163,255,0.67 [0.50-0.91],0.0088292812916292
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign neoplasm: Rectum,23122,406,1.08 [0.85-1.36],0.5346643392499004
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23050,680,0.87 [0.73-1.04],0.1361826211109937
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23150,541,0.85 [0.69-1.03],0.1029655504478441
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Carcinoma in situ of breast,9075,49,1.74 [0.89-3.40],0.1047204717902419
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",9118,65,1.39 [0.78-2.48],0.2700820068207106
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",16551,73,1.30 [0.75-2.25],0.347380110954914
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",16578,100,0.78 [0.49-1.24],0.2904338492927231
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23150,126,0.90 [0.59-1.37],0.6305180447884158
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Haemangioma, any site",23151,123,0.91 [0.60-1.39],0.6615233432568296
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Leiomyoma of uterus,11808,165,1.02 [0.70-1.47],0.9303632190479404
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Lung cancer and mesothelioma,14669,483,0.83 [0.67-1.03],0.094474049263505
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Lymphoid leukaemia,16552,74,0.97 [0.56-1.68],0.9160001395474388
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16701,223,1.43 [1.05-1.96],0.0236088141641894
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",16799,321,0.80 [0.62-1.04],0.1007776994083341
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",9199,105,0.69 [0.43-1.08],0.1059688989927287
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",16588,110,1.00 [0.64-1.55],0.9850233539385514
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",16620,142,1.21 [0.82-1.78],0.3311220239892662
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",16602,124,1.11 [0.73-1.68],0.6376177162893516
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",9182,88,1.04 [0.63-1.72],0.8789052416844815
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",16607,129,1.08 [0.72-1.63],0.7093973308540619
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",8360,976,1.18 [1.01-1.37],0.0311476823603875
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",16615,137,0.93 [0.62-1.39],0.7213921438766898
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",16569,91,0.48 [0.29-0.78],0.0030662271529378
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,16623,145,1.29 [0.87-1.90],0.2010277382568913
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Melanocytic naevi,23061,184,1.08 [0.76-1.52],0.6766759866933412
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Melanocytic naevi of trunk,23179,76,0.96 [0.56-1.64],0.8786726626192343
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Melanoma in situ,16531,111,0.73 [0.47-1.14],0.1676663699554101
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",16601,123,0.81 [0.53-1.23],0.3175177433995545
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16682,204,0.83 [0.60-1.16],0.2824635193537269
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",16807,329,0.81 [0.63-1.05],0.1086410831711361
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",16608,130,0.96 [0.64-1.45],0.8529277411037015
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Other benign neoplasms of skin,23033,164,1.21 [0.84-1.74],0.297323673181886
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",17972,1494,1.17 [1.03-1.32],0.0118994632031592
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",18057,1579,1.18 [1.05-1.33],0.0060365707191973
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22896,395,1.14 [0.90-1.44],0.264995068481167
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,20875,163,5.62 [4.08-7.74],5.0052703993116375e-26
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22572,71,1.20 [0.70-2.08],0.5083628246945959
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22443,3526,1.30 [1.20-1.41],6.339823366593171e-11
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,21473,74,3.18 [1.93-5.26],6.127293624839211e-06
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,22733,66,0.97 [0.54-1.72],0.9051672465653332
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22692,1980,1.47 [1.32-1.63],8.523498678479973e-13
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22690,1978,1.47 [1.32-1.63],9.435509110071673e-13
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,20828,116,1.60 [1.03-2.48],0.0346970840478172
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22843,1444,1.18 [1.05-1.34],0.0068927469081059
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,22782,115,1.46 [0.95-2.23],0.0817790971921829
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22577,76,1.38 [0.82-2.32],0.2316129189253518
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22577,76,1.33 [0.78-2.27],0.2875388623563158
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23026,359,1.65 [1.30-2.09],4.062995456172148e-05
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23076,41,0.60 [0.29-1.26],0.1810914549553461
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",22962,295,1.66 [1.28-2.16],0.000161697258692
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,21536,137,1.15 [0.78-1.72],0.4816779239540786
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,15488,419,1.80 [1.43-2.27],4.376544766047431e-07
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21688,103,1.23 [0.76-1.99],0.3933399235040719
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21699,114,1.04 [0.68-1.59],0.8686945491610967
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,15140,71,0.88 [0.49-1.56],0.656730673841266
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21553,65,1.40 [0.79-2.46],0.2475090488139016
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,20763,318,1.16 [0.90-1.51],0.2598935676109931
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",22408,961,1.41 [1.22-1.64],5.151012871480204e-06
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,21931,484,1.10 [0.89-1.36],0.3650326246930839
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,21666,219,0.78 [0.57-1.07],0.1295110668688236
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,22920,1432,1.14 [1.00-1.28],0.0427908773239425
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,19517,1387,1.13 [0.99-1.28],0.0599645487723968
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",15163,94,1.56 [0.95-2.57],0.0814717603966631
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",20898,102,1.36 [0.86-2.17],0.1907675230753909
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,15440,371,1.50 [1.17-1.93],0.0013060816416917
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,15125,56,1.51 [0.79-2.87],0.2141461309304269
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19706,4637,0.84 [0.78-0.90],1.102259266686241e-06
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,15335,266,1.19 [0.89-1.60],0.2471745667184023
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15784,715,1.20 [1.00-1.44],0.0457383072685176
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23146,371,2.45 [1.95-3.08],1.3490596718097746e-14
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,22938,163,4.24 [3.08-5.83],7.3769985492746e-19
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,15224,155,1.07 [0.73-1.59],0.7199783100025217
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",15151,82,1.63 [0.96-2.77],0.0706467037228115
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22562,1766,1.23 [1.10-1.37],0.0003003619630561
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,15458,389,3.02 [2.40-3.79],2.542003947007888e-21
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,15497,428,2.74 [2.20-3.42],3.9882476668314483e-19
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15936,867,0.92 [0.78-1.09],0.3485626545236788
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,15248,179,1.21 [0.84-1.74],0.2968549794246919
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,22928,153,4.29 [3.09-5.97],4.4288403768949864e-18
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,15968,899,1.47 [1.26-1.73],1.915378698975487e-06
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,15730,661,1.18 [0.98-1.43],0.078752964946455
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,20524,79,1.95 [1.17-3.27],0.01093181845278
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21555,6486,0.97 [0.92-1.03],0.3819427762057382
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,20857,61,1.75 [0.97-3.16],0.0625883442885829
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,20847,51,0.93 [0.48-1.80],0.819243190398109
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23020,1913,0.98 [0.88-1.09],0.6501902627224199
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23018,1911,0.98 [0.88-1.09],0.6907116056690961
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,20862,66,1.38 [0.78-2.44],0.2665748585308597
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,22853,1139,1.09 [0.95-1.25],0.2208085412261328
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",17323,2254,1.49 [1.35-1.64],3.032172609380277e-15
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23191,317,2.22 [1.74-2.83],1.1503218324806763e-10
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,21578,131,1.31 [0.88-1.96],0.1872712649740655
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,21831,117,1.39 [0.91-2.12],0.1325917919828841
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,21879,165,1.01 [0.70-1.45],0.9769587985284314
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",15272,203,1.27 [0.90-1.78],0.173369436238582
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20394,186,1.07 [0.76-1.50],0.7090040939542755
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2490,100,2.41 [1.63-3.55],9.524959225622744e-06
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2661,313,1.23 [0.97-1.57],0.0863692728870671
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20294,86,2.15 [1.32-3.49],0.0020625266085536
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2463,76,7.33 [5.06-10.62],7.091598361104458e-26
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22355,2147,0.57 [0.51-0.63],9.429160735029154e-27
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22079,632,1.15 [0.96-1.39],0.127732881123932
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,20897,452,1.23 [0.98-1.53],0.0702796966375984
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,16192,1123,1.42 [1.24-1.64],1.1288707617294409e-06
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23070,303,2.15 [1.67-2.77],2.812586348034489e-09
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),21699,269,0.76 [0.57-1.01],0.0604318843998396
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Angina pectoris,20031,1576,0.74 [0.65-0.83],7.322815586351178e-07
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Aortic aneurysm,21806,376,0.83 [0.65-1.06],0.1350083870331484
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,21519,89,1.91 [1.19-3.08],0.0075094058916733
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",21723,293,1.28 [0.98-1.68],0.0713220572284475
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11738,2856,1.25 [1.15-1.37],7.207863795523874e-07
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,AV-block,17611,674,1.17 [0.97-1.40],0.0983289248630561
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23125,579,1.28 [1.06-1.55],0.0115867542239448
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Cardiac arrest,9147,265,1.44 [1.06-1.95],0.0202696750860484
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Cardiomyopathy,17140,203,1.38 [0.99-1.93],0.0591534289466739
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",17046,109,1.50 [0.95-2.37],0.0787062057066764
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23202,78,1.44 [0.86-2.40],0.1662141338695852
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Conduction disorders,18499,1562,1.17 [1.03-1.32],0.0118654454726488
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21198,2768,0.90 [0.83-0.99],0.0256535886940314
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18617,8935,0.98 [0.93-1.03],0.4496785776803524
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21619,334,2.11 [1.66-2.70],1.8799047286689227e-09
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Endocarditis,17040,103,1.20 [0.75-1.92],0.4503552809954434
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22913,1677,1.44 [1.28-1.61],1.9966273990685247e-10
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Hypertension,19863,7953,0.93 [0.88-0.98],0.0065832663282003
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Hypertension, essential",19884,7974,0.93 [0.89-0.99],0.0151634747133722
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23034,96,1.38 [0.87-2.19],0.1702421598250065
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12174,264,1.55 [1.15-2.09],0.0036578695773779
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12115,205,9.06 [7.05-11.64],1.9691375440689602e-66
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Hypotension,23024,1651,1.38 [1.23-1.54],2.4262851669321857e-08
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,21902,149,1.08 [0.74-1.59],0.6811986535056092
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",21370,2915,0.91 [0.83-0.99],0.0344559307770777
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22689,808,1.14 [0.97-1.34],0.1166367923014422
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Left bundle-branch block,17465,528,1.37 [1.11-1.68],0.0030544132119335
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22505,1070,0.89 [0.77-1.03],0.1169201730035455
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19377,922,0.86 [0.74-1.01],0.0592123367606289
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23075,189,0.87 [0.62-1.22],0.4084593324494135
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23162,414,0.78 [0.62-0.98],0.0324770510567324
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Oesophageal varices,21353,68,0.85 [0.49-1.50],0.5816748247197812
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other aneurysm,21534,104,1.40 [0.89-2.21],0.1464695551750038
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other arrhythmias,17536,599,1.19 [0.98-1.45],0.0818046676711955
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,21567,137,1.55 [1.05-2.29],0.0271019924754588
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21765,335,1.24 [0.96-1.59],0.100010761153278
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,17160,223,1.18 [0.86-1.63],0.3056685848993014
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other disorders of veins,21407,122,1.81 [1.22-2.70],0.0034085092828122
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,21330,45,1.26 [0.64-2.51],0.5043200754055814
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,21128,90,1.01 [0.62-1.66],0.9539652140599608
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,21468,183,1.70 [1.23-2.35],0.0014525715469322
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,18413,1476,1.30 [1.15-1.46],2.9921900437539296e-05
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,21436,63,1.96 [1.11-3.45],0.0203562060378826
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22161,731,1.34 [1.13-1.59],0.0007518077725355
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22429,529,1.48 [1.21-1.79],8.939203495629497e-05
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22025,987,1.24 [1.07-1.44],0.0039219570951422
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9302,420,1.06 [0.83-1.35],0.6589854711014955
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Peripheral artery disease,21990,595,1.36 [1.12-1.64],0.0014198792662628
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21707,422,1.77 [1.42-2.20],4.562829068048438e-07
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22506,606,1.36 [1.13-1.65],0.0011141027354089
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23105,983,1.34 [1.16-1.55],8.251373196608676e-05
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Right bundle-branch block,17456,519,1.07 [0.87-1.32],0.5263717844617869
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22422,522,1.46 [1.20-1.78],0.0001504882166153
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,21306,268,1.64 [1.24-2.16],0.0005023037997091
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22673,920,1.13 [0.97-1.31],0.1229864822844962
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22658,961,1.14 [0.98-1.33],0.0837311399012224
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,21870,63,1.03 [0.57-1.85],0.9312163371601524
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,21537,107,1.16 [0.74-1.83],0.522096757444604
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22206,325,0.97 [0.75-1.25],0.7972652227433327
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21770,335,0.76 [0.59-0.98],0.0343903513559204
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Varicose veins,21809,524,1.49 [1.22-1.82],0.0001135327782177
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,21447,120,1.14 [0.74-1.75],0.5439335919656141
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22928,952,1.49 [1.28-1.72],1.279361924527749e-07
CD300LG,CMRF35-like molecule 9,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23125,336,1.21 [0.94-1.55],0.1403082764488755
CD300LG,CMRF35-like molecule 9,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19810,1385,1.07 [0.94-1.21],0.2921967909282378
CD300LG,CMRF35-like molecule 9,Chapter V Mental and behavioural disorders,Any mental disorder,22670,4245,1.08 [1.01-1.16],0.0333030716822596
CD300LG,CMRF35-like molecule 9,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23096,396,1.18 [0.94-1.49],0.1507022787881656
CD300LG,CMRF35-like molecule 9,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19884,1459,1.14 [1.01-1.29],0.0374394413055487
CD300LG,CMRF35-like molecule 9,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18512,87,1.03 [0.63-1.70],0.9001726573410886
CD300LG,CMRF35-like molecule 9,Chapter V Mental and behavioural disorders,Smoking dependency,22687,1189,0.97 [0.85-1.12],0.7048103845865805
CD300LG,CMRF35-like molecule 9,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19888,1463,1.04 [0.92-1.17],0.5630107486304257
CD300LG,CMRF35-like molecule 9,Chapter V Mental and behavioural disorders,Vascular dementia,22297,231,1.09 [0.81-1.48],0.5584690145066304
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Alzheimer disease,23204,594,1.09 [0.90-1.32],0.3787355744532031
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",14192,111,1.10 [0.70-1.72],0.6776883774736377
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Bell's palsy,21347,84,0.98 [0.59-1.64],0.953869446489531
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21753,490,0.90 [0.73-1.11],0.3170085663080643
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Cerebral cysts,22749,250,1.39 [1.04-1.87],0.0258131362963178
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23129,417,1.34 [1.07-1.67],0.010426557996725
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,22347,76,0.74 [0.43-1.27],0.2718305762785217
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23185,68,1.16 [0.66-2.02],0.612557317889794
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22586,87,1.42 [0.86-2.32],0.1682892966616169
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Epilepsy,21684,306,1.65 [1.27-2.14],0.000183374083982
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22737,1359,1.16 [1.03-1.32],0.0179347770919158
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23149,924,0.97 [0.84-1.14],0.733838750964166
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22543,3474,1.32 [1.22-1.42],6.109447318880417e-12
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Generalized epilepsy,22822,54,1.72 [0.93-3.19],0.0835776016049699
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Hemiplegia,23053,341,1.34 [1.04-1.71],0.021296369793503
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Hydrocephalus,22573,74,0.83 [0.48-1.45],0.5192496165531424
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23191,74,1.15 [0.67-1.98],0.6132303126205414
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21330,67,0.75 [0.42-1.34],0.3280380061708846
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21336,73,0.79 [0.46-1.37],0.4078254122964915
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Memory loss,22047,143,0.95 [0.64-1.40],0.7940375678938789
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Migraine,21656,278,1.14 [0.86-1.51],0.3621681627418599
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23157,257,1.22 [0.91-1.63],0.1874056686955267
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Motor neuron disease,14279,175,0.82 [0.57-1.18],0.2786114334628776
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23071,62,1.41 [0.78-2.53],0.2539460203616141
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22494,1231,1.04 [0.91-1.19],0.5292317107667204
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Neurological diseases,21707,4376,1.11 [1.03-1.19],0.0047459048218705
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,22599,328,1.18 [0.91-1.52],0.2089749515002069
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21694,431,0.98 [0.78-1.22],0.8291344639987495
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23123,355,1.82 [1.43-2.30],7.72767864259892e-07
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,17343,984,1.14 [0.98-1.32],0.0870881947002148
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22585,86,1.50 [0.92-2.45],0.1069223741946472
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Other disorders of nervous system,22661,162,1.54 [1.08-2.20],0.0164091741728354
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,22461,236,1.18 [0.87-1.59],0.2896988692350855
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21359,96,1.03 [0.64-1.66],0.9013664301706804
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Other headache syndromes,21430,52,0.81 [0.42-1.56],0.5340972988857468
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Other neurological diseases,23086,587,1.27 [1.05-1.54],0.0134531746535774
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Other sleep disorders,21898,520,1.12 [0.92-1.38],0.2604081432668184
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Parkinson's disease,23170,684,0.95 [0.79-1.13],0.5520396826087981
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22545,46,1.10 [0.55-2.20],0.7948770067697616
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Restless leg syndrome,23204,107,1.32 [0.85-2.06],0.2205179636029878
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Sleep apnoea,22969,442,1.18 [0.95-1.47],0.1351965006631411
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Small fibre neuropathy,22830,62,2.25 [1.28-3.93],0.0046503154962172
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23193,202,0.83 [0.60-1.16],0.2782572105544025
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21334,71,1.21 [0.70-2.10],0.5004910979911258
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23204,600,1.09 [0.90-1.32],0.3585059089854728
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),22236,225,1.15 [0.85-1.57],0.3601280933296441
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22555,154,1.15 [0.79-1.67],0.478331209105877
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,22750,572,0.88 [0.72-1.07],0.1887453567330865
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22948,270,0.92 [0.70-1.22],0.5812062811011632
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,21970,68,0.82 [0.46-1.44],0.4869224103665546
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,21938,36,0.96 [0.44-2.10],0.9217679980448952
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23079,73,1.13 [0.66-1.93],0.6602053644541541
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,22891,229,1.16 [0.85-1.58],0.354716497809218
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2467,77,6.76 [4.65-9.82],1.2313924619585746e-23
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,3043,114,2.50 [1.78-3.53],1.649271833276164e-07
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22508,107,1.74 [1.12-2.70],0.0144056417253645
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22907,1430,1.04 [0.92-1.17],0.5633522023046151
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22785,883,1.02 [0.88-1.20],0.7683168983292635
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22203,301,1.03 [0.78-1.34],0.8532538777836255
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23131,953,0.86 [0.74-1.00],0.0531517732346287
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23198,81,1.07 [0.63-1.79],0.8113006983910764
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23058,880,0.84 [0.72-0.99],0.0337107492033221
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23161,499,0.94 [0.76-1.16],0.5865167048988176
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23083,226,1.25 [0.92-1.70],0.1530914673371082
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22001,99,1.02 [0.64-1.64],0.9199083155169724
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22007,105,1.01 [0.64-1.59],0.9714856754832476
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,21980,78,0.97 [0.57-1.64],0.9094488062431544
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23066,1013,1.02 [0.88-1.18],0.7833255282992408
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,22314,261,1.14 [0.85-1.52],0.3832712554940609
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22247,69,0.63 [0.36-1.10],0.1025493281758706
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,22783,121,0.79 [0.52-1.21],0.2859292391121759
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23055,393,1.05 [0.83-1.32],0.7081205040925844
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22398,220,0.86 [0.62-1.18],0.3400914681862721
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,22998,141,1.18 [0.80-1.75],0.4070122188359817
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22734,681,1.01 [0.85-1.21],0.8902239558847181
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22561,160,1.07 [0.74-1.55],0.7185356718474731
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20746,3255,1.02 [0.93-1.10],0.7179608118205679
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23009,347,0.99 [0.77-1.28],0.9481593613642512
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23189,190,1.23 [0.88-1.72],0.2344231240351807
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22446,544,1.02 [0.84-1.24],0.8496717607077555
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,22751,89,0.79 [0.48-1.30],0.3513842670431855
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23189,72,0.98 [0.57-1.70],0.9485592057866922
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22028,126,1.36 [0.91-2.05],0.1370500611256355
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22079,177,0.76 [0.54-1.08],0.1306960247112813
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,21644,167,0.81 [0.56-1.17],0.2554971183999476
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22241,63,1.48 [0.83-2.63],0.1875708637188165
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",21550,73,0.76 [0.44-1.32],0.3314022582316593
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22165,112,1.06 [0.68-1.64],0.8011554637931231
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",22349,296,0.88 [0.67-1.15],0.3526227465632217
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22061,159,1.52 [1.06-2.17],0.0231944890988641
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,21571,94,1.14 [0.70-1.85],0.6079276059771239
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,21611,134,1.15 [0.76-1.72],0.5148290712021877
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20235,2744,0.96 [0.87-1.05],0.3346488453675571
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,21995,93,1.28 [0.80-2.07],0.3041018216477704
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22907,506,1.06 [0.87-1.31],0.55096755782933
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22481,80,0.66 [0.39-1.11],0.1208289450075074
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22610,209,1.26 [0.92-1.74],0.1543438827553979
CD300LG,CMRF35-like molecule 9,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,22978,114,1.04 [0.67-1.61],0.8754218266178571
CD300LG,CMRF35-like molecule 9,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23156,140,0.99 [0.67-1.46],0.9552024963868534
CD300LG,CMRF35-like molecule 9,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23067,120,1.06 [0.69-1.62],0.7959164968857876
CD300LG,CMRF35-like molecule 9,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,22930,66,1.47 [0.83-2.59],0.1845088005389229
CD300LG,CMRF35-like molecule 9,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,22933,69,0.78 [0.44-1.38],0.3876654890070441
CD300LG,CMRF35-like molecule 9,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23099,1245,1.08 [0.94-1.23],0.2770573229365253
CD300LG,CMRF35-like molecule 9,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,22795,941,1.07 [0.92-1.25],0.3834848882541863
CD300LG,CMRF35-like molecule 9,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22007,153,1.06 [0.73-1.55],0.7614024238120658
CD300LG,CMRF35-like molecule 9,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,21943,89,0.85 [0.52-1.41],0.5376187119851462
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Acute pharyngitis,23010,66,1.87 [1.08-3.24],0.0262199105754071
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23131,187,1.58 [1.13-2.19],0.0071894614483694
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23007,63,1.80 [1.03-3.16],0.0400097758891627
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,All influenza,20509,157,1.44 [0.99-2.09],0.0558341483870212
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),20506,154,1.45 [1.00-2.12],0.0526614066221099
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Allergic asthma (mode),14291,105,1.11 [0.70-1.77],0.6537743683179551
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Allergic rhinitis,23095,239,1.02 [0.75-1.38],0.920808767778152
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15505,1716,1.01 [0.90-1.14],0.8204079660528929
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",15881,1695,1.02 [0.91-1.14],0.7448506540878572
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),22685,179,1.85 [1.32-2.58],0.0003486754254797
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",20456,104,1.42 [0.90-2.25],0.1315528431304879
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Bronchiectasis,19456,523,1.10 [0.90-1.35],0.3672132286733942
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",19005,72,1.50 [0.87-2.58],0.1444678044602401
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22070,3137,1.04 [0.95-1.13],0.3937250381224375
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",21973,72,1.25 [0.72-2.16],0.42581099661932
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Chronic sinusitis,22034,133,1.07 [0.72-1.60],0.7376735274454161
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22907,1641,1.01 [0.90-1.13],0.902630996828252
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Deviated nasal septum,21982,81,0.88 [0.52-1.49],0.6391768332730654
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21044,6134,1.06 [1.00-1.13],0.058013418040151
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22241,340,0.98 [0.76-1.26],0.8829809820770919
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Early onset COPD,21377,111,1.17 [0.75-1.83],0.5011898052362114
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Emphysema,19368,435,1.03 [0.82-1.28],0.8080187346601688
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21891,456,0.94 [0.76-1.17],0.6087560195911768
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22944,2592,1.29 [1.18-1.42],2.578265600936007e-08
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Interstitial lung disease,21935,500,0.91 [0.74-1.12],0.3582376935370146
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Later onset COPD,22675,1530,1.00 [0.89-1.12],0.985711754281226
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23187,498,1.40 [1.14-1.72],0.0012017514685701
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Nasal polyp,21998,97,1.08 [0.67-1.72],0.7590031452226342
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22922,1311,1.30 [1.14-1.47],5.0656878835866565e-05
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Other diseases of pleura,22912,2700,1.24 [1.14-1.36],1.393251373499137e-06
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22657,756,0.93 [0.79-1.11],0.4198035471562903
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Other pleural conditions,20281,69,1.52 [0.87-2.66],0.1391375772445444
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23082,596,1.04 [0.86-1.26],0.6614593454138689
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23073,1720,1.22 [1.09-1.37],0.0004281973222512
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Pleural effusion,21582,1370,1.37 [1.21-1.55],7.922109905830572e-07
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Pleural plaque,20467,255,1.08 [0.81-1.45],0.601833766801075
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22655,2303,1.30 [1.18-1.43],9.4041830956031e-08
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23077,388,1.58 [1.26-1.99],8.915738978524195e-05
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Pneumothorax,20381,169,1.14 [0.79-1.63],0.4807258191819675
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Pollen allergy,23192,203,1.06 [0.76-1.48],0.7283410804524977
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Pulmonary oedema,22576,90,2.17 [1.38-3.42],0.0008019032894633
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Respiratory insufficiency,14257,71,1.56 [0.90-2.71],0.1136569685680634
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22898,1287,1.33 [1.17-1.51],1.3377331272714996e-05
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22142,241,1.00 [0.74-1.35],0.9927917901014274
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Viral pneumonia,20654,302,1.37 [1.05-1.79],0.0225284919074051
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",22696,241,1.35 [1.00-1.82],0.0482565489135512
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7383,122,0.79 [0.51-1.23],0.3030186040354165
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14681,62,0.94 [0.52-1.71],0.848729956448764
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Acute appendicitis,23088,127,0.73 [0.48-1.11],0.1436639072685709
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Acute gastritis,16121,103,1.38 [0.87-2.18],0.1695842012498282
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Acute pancreatitis,21151,198,1.14 [0.82-1.58],0.4271608365020866
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Acute peritonitis,22705,113,2.18 [1.44-3.30],0.0002197858967283
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22228,65,1.22 [0.69-2.16],0.4885398155918029
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Barrett oesophagus,16529,511,1.18 [0.96-1.46],0.1095568290280934
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21099,146,1.01 [0.69-1.48],0.9635834422307966
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",22779,146,1.00 [0.68-1.47],0.9933485003148402
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Cholecystitis,21175,222,1.21 [0.89-1.64],0.2226862783311311
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Cholelithiasis,22013,1060,0.93 [0.81-1.07],0.3318462753062255
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Chronic gastritis,16364,346,1.02 [0.79-1.31],0.8974043313800258
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21007,54,0.60 [0.32-1.14],0.1179216050417482
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23065,127,1.34 [0.90-2.01],0.1535252769402839
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Coeliac disease,21453,128,0.53 [0.35-0.80],0.0026687918777377
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Collagenous colitis,21444,103,0.96 [0.60-1.54],0.8806961913243871
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23086,158,0.90 [0.62-1.30],0.5658233366795511
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Constipation,22918,2145,1.12 [1.01-1.24],0.0261314207845634
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Crohn disease,21431,90,1.30 [0.80-2.11],0.2954952792189191
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22850,69,1.04 [0.60-1.82],0.8793070650123027
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21423,82,1.17 [0.70-1.96],0.544435515116594
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Dental caries,22581,188,1.07 [0.77-1.51],0.6783756913237662
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20038,2576,1.03 [0.94-1.13],0.5099583544530812
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Diseases of appendix,23119,158,0.70 [0.48-1.02],0.0630379413426748
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Diseases of liver,23085,922,1.05 [0.90-1.22],0.5498727504936172
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20640,4622,1.07 [1.00-1.14],0.0628884431867185
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22870,477,1.08 [0.87-1.33],0.4967291183574749
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23110,518,1.27 [1.03-1.56],0.0222023637892212
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22486,93,1.43 [0.89-2.30],0.1412799440872441
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22357,58,0.83 [0.45-1.53],0.5424060541353027
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22863,1538,1.04 [0.93-1.18],0.4730947541365958
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Diseases of tongue,22376,98,1.31 [0.82-2.10],0.2573974847269744
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22482,1529,1.01 [0.90-1.14],0.8299316457464185
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18427,3808,0.92 [0.85-0.99],0.0297232728468974
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Duodenal ulcer,16270,252,1.11 [0.83-1.49],0.4904961508605457
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23110,205,0.89 [0.65-1.24],0.503251472103246
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23165,27,0.97 [0.39-2.40],0.9435312501071073
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22311,148,1.38 [0.95-2.01],0.0869680868007476
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14726,107,0.97 [0.62-1.53],0.9049041249622074
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Functional dyspepsia,16582,564,0.89 [0.72-1.08],0.2309131309203549
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Gastric ulcer,16450,432,1.25 [1.00-1.56],0.0477574986472691
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18705,2687,1.02 [0.93-1.11],0.7358582261750979
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16678,660,1.22 [1.02-1.46],0.0326427591377787
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16750,8264,0.99 [0.94-1.05],0.784418120623886
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,GI-bleeding,22603,1278,1.13 [0.99-1.28],0.0674740223301998
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22438,45,1.20 [0.60-2.39],0.607884464675424
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,15614,1187,0.86 [0.75-0.98],0.0283953545113716
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22234,71,1.48 [0.86-2.54],0.1564070546072295
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Hernia,21135,3673,1.02 [0.94-1.10],0.6744577060172467
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Impacted teeth,23169,25,0.99 [0.38-2.54],0.9800668574408218
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Impaction of intestines,14695,76,1.07 [0.62-1.82],0.8170306189143515
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Inguinal hernia,18572,1110,0.98 [0.86-1.13],0.8303733033838019
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",17587,125,0.86 [0.56-1.31],0.4884112214659283
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14737,118,1.40 [0.91-2.14],0.1270227635457252
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21472,147,0.53 [0.36-0.79],0.0016467478036678
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,15136,517,1.04 [0.85-1.28],0.7050098654186856
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23172,337,0.77 [0.60-0.99],0.0417643473121873
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22132,791,1.28 [1.09-1.51],0.0026625297704364
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22441,1100,1.22 [1.06-1.41],0.0047517928476179
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Oesophageal obstruction,16239,221,0.93 [0.67-1.27],0.6364885605935138
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Oesophagitis,16714,696,1.22 [1.02-1.45],0.0293227816258851
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23150,135,0.87 [0.58-1.31],0.5074393943325908
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,17549,87,0.91 [0.55-1.51],0.7182906591073013
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,16003,1384,0.82 [0.72-0.93],0.0025525645362819
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21313,360,0.97 [0.76-1.24],0.8238211094824626
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21098,145,1.24 [0.84-1.81],0.2743329512041724
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of intestine,16567,1948,1.02 [0.92-1.13],0.7162200047271513
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of intestines,20873,6254,0.98 [0.93-1.04],0.5970728932725469
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22339,210,0.82 [0.60-1.14],0.242004235074263
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of liver,22923,760,1.04 [0.88-1.23],0.6335636443625832
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16794,776,1.24 [1.05-1.46],0.0127491443513993
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21170,217,1.17 [0.86-1.61],0.3162477132509109
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23031,439,1.07 [0.86-1.34],0.5439116004619604
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,17121,1103,1.07 [0.93-1.24],0.3365392540135997
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22620,1295,1.13 [0.99-1.29],0.0612212653908857
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22574,181,1.02 [0.72-1.44],0.914012934846424
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16811,2192,1.08 [0.98-1.19],0.1246417612855194
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18200,2182,1.04 [0.94-1.15],0.4148415734900793
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22276,113,0.95 [0.62-1.47],0.8246378249751387
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22310,969,1.22 [1.05-1.41],0.0093009799896586
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",15069,450,1.11 [0.89-1.39],0.343188377318718
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23161,31,1.06 [0.46-2.48],0.886736373152473
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,15240,621,1.11 [0.92-1.34],0.2637815590935356
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21483,158,1.05 [0.72-1.52],0.8029032076700511
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23191,51,1.32 [0.69-2.51],0.3995661379383733
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22386,100,1.52 [0.95-2.41],0.0778663383292169
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Toxic colitis,21421,80,1.07 [0.63-1.80],0.8120601881877347
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,16360,342,1.14 [0.88-1.46],0.3251044969046904
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Ulcerative colitis,21509,168,1.06 [0.74-1.52],0.7588699603930109
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21476,135,0.97 [0.65-1.46],0.8876433247856631
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Umbilical hernia,17720,258,0.86 [0.64-1.15],0.3047089037244976
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,14862,243,1.15 [0.85-1.56],0.3482201130527288
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Ventral hernia,17753,291,0.98 [0.74-1.28],0.857630158944898
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Volvulus,14713,94,0.68 [0.42-1.11],0.1190598763710014
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23097,427,1.40 [1.12-1.75],0.0031555632223144
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,22837,66,0.80 [0.45-1.42],0.4470058502520834
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20641,169,1.03 [0.72-1.49],0.8616961820073645
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22569,837,1.76 [1.51-2.06],7.781319909293903e-13
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21878,146,1.54 [1.05-2.26],0.0260399138231469
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21110,638,1.70 [1.43-2.04],5.317807374454596e-09
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,22859,316,0.95 [0.73-1.23],0.6948466477662893
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23103,560,1.09 [0.90-1.33],0.3788463793508876
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22590,47,1.27 [0.64-2.51],0.4874206236873689
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21596,3745,1.25 [1.16-1.35],6.609838591876737e-09
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22766,438,0.83 [0.66-1.03],0.0965035948024675
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22632,304,0.77 [0.59-1.01],0.0605265327572637
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22816,1084,1.63 [1.42-1.86],4.224696280779909e-12
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23183,60,1.05 [0.57-1.91],0.886425764661171
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,20529,57,1.68 [0.92-3.08],0.0914628690717841
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22391,63,0.98 [0.55-1.74],0.9333437388135024
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,22846,303,0.98 [0.75-1.29],0.8987367802418336
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21080,608,1.33 [1.10-1.60],0.0037954198738106
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,20562,90,1.75 [1.08-2.84],0.0237869310553093
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23114,95,2.41 [1.55-3.74],8.960671335286592e-05
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,21968,236,1.57 [1.17-2.12],0.0028916702003273
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,22997,226,1.07 [0.78-1.46],0.6709504822698418
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22639,96,2.32 [1.49-3.62],0.0001997704585566
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,20549,77,0.85 [0.50-1.47],0.5690936977062435
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22591,2119,1.40 [1.27-1.55],4.1392525970808754e-11
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21125,653,1.36 [1.13-1.63],0.001103506431714
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,20566,94,1.67 [1.04-2.69],0.0339212045962823
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23111,340,1.02 [0.79-1.32],0.8701041600939633
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,22619,76,1.21 [0.71-2.05],0.4904937540403332
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23049,278,1.01 [0.77-1.34],0.9221565992606834
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23129,459,1.40 [1.12-1.73],0.002436123649479
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20598,126,1.06 [0.69-1.62],0.7944277085840079
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,20811,339,1.05 [0.81-1.35],0.73636459108393
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23118,448,1.39 [1.12-1.73],0.0030303064107542
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",20813,341,2.42 [1.92-3.07],1.7904523867461076e-13
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23176,157,1.82 [1.27-2.59],0.0010280597525736
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,19341,83,0.68 [0.40-1.13],0.1367664879100375
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20433,6471,1.12 [1.06-1.19],0.0001415883795292
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19015,5053,1.10 [1.03-1.18],0.0035872731500029
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,19312,54,0.79 [0.42-1.49],0.4655373567737058
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,19252,148,1.65 [1.13-2.41],0.0088831787506448
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,19297,193,2.30 [1.67-3.18],4.0907897720063225e-07
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,22937,65,1.33 [0.75-2.36],0.3247099671428713
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",19257,153,1.41 [0.97-2.05],0.0740568054419742
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15454,1492,1.14 [1.01-1.29],0.0388205576471201
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",22992,247,1.11 [0.82-1.48],0.501430875789878
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,19698,594,1.29 [1.07-1.57],0.0089141881350394
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18762,8067,1.11 [1.05-1.17],0.0001560158112494
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20640,122,1.42 [0.93-2.16],0.1054093503977312
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,19443,185,1.29 [0.92-1.81],0.1396229879226025
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19760,502,0.90 [0.73-1.11],0.3325268275079193
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22264,3160,1.14 [1.05-1.24],0.0015527093187288
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19571,313,1.18 [0.90-1.53],0.2267190714885202
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,19409,151,1.00 [0.68-1.46],0.9917044073948345
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,19371,113,0.75 [0.48-1.17],0.2020541559503888
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22451,103,0.84 [0.53-1.33],0.452217919863221
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,15985,2023,1.16 [1.04-1.28],0.0053656823855735
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14767,805,1.61 [1.37-1.88],5.036162088056147e-09
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23105,798,1.57 [1.34-1.85],2.3054565455032443e-08
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14038,76,1.00 [0.58-1.73],0.9875320326733068
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14265,303,1.31 [1.00-1.72],0.0525575166092573
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,19523,265,0.85 [0.64-1.14],0.2742230960753769
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14446,484,1.10 [0.89-1.36],0.3839674743447776
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,19186,82,2.01 [1.21-3.32],0.0068336655611737
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,19796,692,1.10 [0.92-1.32],0.2913312240154512
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,19426,322,0.92 [0.71-1.20],0.5339354028653731
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14415,453,1.08 [0.86-1.35],0.5108738953299975
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,19330,72,0.78 [0.45-1.36],0.3835069299176228
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",19317,59,1.56 [0.86-2.82],0.1446004315196186
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,20604,86,2.64 [1.66-4.20],4.445824665182172e-05
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22769,2251,1.39 [1.26-1.53],5.7461642813655614e-11
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22093,1575,1.43 [1.27-1.60],2.708578773971213e-09
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23028,546,1.22 [1.00-1.49],0.0494128142945058
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,17110,3148,1.12 [1.03-1.22],0.0077224355621758
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,14005,43,0.70 [0.34-1.44],0.332409394484322
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,19363,105,1.58 [1.01-2.47],0.0441993118302142
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,14034,72,0.96 [0.55-1.66],0.8862392364309855
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14100,138,1.12 [0.75-1.68],0.5825198264100947
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20765,247,1.35 [1.01-1.81],0.0458511383331633
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21033,515,1.39 [1.13-1.71],0.0017034746089647
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23180,115,1.38 [0.89-2.12],0.1459953987679155
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21107,2003,1.19 [1.07-1.32],0.000948671876496
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19335,77,1.23 [0.72-2.09],0.4523510448525913
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14115,153,1.44 [0.98-2.10],0.0609637923402224
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,19909,805,1.11 [0.94-1.31],0.2030605047170527
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,16158,2196,1.24 [1.13-1.37],1.738989002503224e-05
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22478,130,1.12 [0.74-1.69],0.5837974965695449
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23192,63,0.77 [0.43-1.38],0.3776623705733896
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19336,78,0.61 [0.36-1.04],0.0708387257337487
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20619,1361,1.16 [1.03-1.32],0.0188670165302697
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,19368,110,1.64 [1.06-2.53],0.0267592548034144
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,16035,2073,1.06 [0.96-1.17],0.2703874151849038
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20638,120,1.09 [0.71-1.68],0.6893287844221752
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,19295,37,0.90 [0.41-1.98],0.8014587922108203
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,19299,195,1.39 [1.00-1.94],0.0519326801354243
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,19949,691,1.37 [1.15-1.63],0.0004180630959146
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22840,492,1.08 [0.88-1.34],0.4626830093484944
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,19768,664,1.39 [1.16-1.66],0.0003887314375738
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23043,540,1.22 [1.00-1.49],0.0460986834062484
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23177,69,0.94 [0.53-1.65],0.8239249702490609
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19425,167,0.88 [0.61-1.27],0.4897594630126569
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18042,895,1.38 [1.18-1.61],4.743264027021814e-05
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,19907,649,1.13 [0.94-1.35],0.1972411638437018
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19539,281,1.16 [0.88-1.53],0.3020163641832093
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",14034,72,1.04 [0.59-1.81],0.8990552077425047
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,17098,3136,1.13 [1.04-1.23],0.0039455441983778
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14808,846,1.21 [1.03-1.43],0.0186242228034402
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22722,374,0.97 [0.76-1.24],0.8071825258588987
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23147,82,1.77 [1.07-2.92],0.0255256323149701
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",20524,72,1.05 [0.62-1.79],0.8489805206081765
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,14026,64,0.83 [0.46-1.50],0.5328850685573454
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,19210,106,1.13 [0.72-1.79],0.5954441059612676
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14516,554,1.25 [1.03-1.52],0.0270771404693081
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19598,340,1.06 [0.82-1.37],0.653300533390473
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,19390,286,1.54 [1.17-2.03],0.0018852944363027
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,19376,272,1.37 [1.03-1.82],0.0298870153064105
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,16284,68,1.10 [0.62-1.95],0.7432458805133324
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23182,74,0.87 [0.50-1.49],0.6059151832730242
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,19816,558,0.92 [0.75-1.12],0.4165487206977222
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],22444,96,1.22 [0.76-1.96],0.4172313327581702
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21911,2653,1.11 [1.02-1.22],0.0217152095007845
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19408,150,0.79 [0.54-1.17],0.2416043332076692
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,19823,719,1.05 [0.88-1.25],0.579948828988836
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,21818,274,1.32 [1.00-1.74],0.0519418057605306
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,19362,258,1.05 [0.78-1.41],0.7474885396841676
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21119,2015,1.16 [1.05-1.29],0.0051819634967048
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20417,1313,1.20 [1.05-1.36],0.0066674309004815
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],19321,63,1.47 [0.82-2.63],0.1949397813946836
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22466,118,1.41 [0.92-2.15],0.1115600745879747
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19420,162,1.05 [0.73-1.52],0.7854106187707574
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,19350,92,0.81 [0.50-1.32],0.401250376843895
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),14040,78,1.41 [0.83-2.38],0.2032364173591577
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21684,2271,2.02 [1.83-2.23],3.7306423812739696e-45
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9291,25,0.32 [0.12-0.82],0.0173293625377924
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11782,33,1.51 [0.67-3.40],0.3247619304070794
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22868,309,0.78 [0.59-1.01],0.0622780829806238
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22663,104,1.03 [0.65-1.62],0.9086842593865462
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21759,2346,3.42 [3.12-3.76],1.2120597003989308e-150
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,22970,131,8.31 [6.21-11.11],3.430432766060951e-46
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,22896,409,1.52 [1.21-1.91],0.0002901007335973
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Cystitis,19307,300,1.16 [0.88-1.52],0.2969554077253988
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Dialysis,19509,96,21.42 [15.52-29.56],1.499871301467695e-77
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10227,2146,1.01 [0.91-1.11],0.9220064350693292
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Disorders of breast,11882,133,0.94 [0.63-1.41],0.7687551596899365
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Endometriosis,9305,39,0.57 [0.27-1.21],0.1421239007548075
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9849,583,0.75 [0.62-0.92],0.0046246229021646
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,19105,6319,1.24 [1.17-1.32],5.910553456295397e-12
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,22936,97,6.36 [4.34-9.30],1.6126456053922285e-21
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Hydrocele,8198,117,0.88 [0.57-1.37],0.5790210768376016
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,19485,350,1.48 [1.14-1.92],0.0034386427169374
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9913,1832,1.00 [0.90-1.12],0.9510914317347604
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,11949,159,0.87 [0.60-1.25],0.4448104888744829
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),8208,127,1.08 [0.71-1.64],0.7116757486639937
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,19097,90,1.27 [0.78-2.08],0.3371106584000954
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10301,1035,0.86 [0.74-0.99],0.0388982708231241
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,8140,59,0.52 [0.28-0.97],0.0387514710961103
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9306,40,1.17 [0.57-2.39],0.6729774581433376
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23189,90,0.99 [0.60-1.62],0.9646588690446628
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23192,86,1.02 [0.62-1.69],0.9257853206474764
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,21986,2979,1.14 [1.05-1.24],0.0025269095355691
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,19960,953,1.09 [0.93-1.27],0.2900579892545236
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11800,51,1.12 [0.59-2.14],0.7234963414217923
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23118,631,1.80 [1.50-2.15],1.838435727255756e-10
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8233,152,1.14 [0.78-1.67],0.4913926388735069
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,8238,157,1.38 [0.95-1.99],0.0877035068782814
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,8234,153,1.35 [0.93-1.96],0.1143002161472791
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23163,86,1.20 [0.73-1.97],0.4826446115655237
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21379,2372,1.24 [1.13-1.36],1.1685311489599504e-05
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,11872,82,0.98 [0.58-1.65],0.9393475349993886
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9333,67,1.33 [0.75-2.37],0.3330771180204552
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9406,140,1.07 [0.72-1.59],0.7213391581183874
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9318,52,0.55 [0.28-1.06],0.0751543378138961
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9368,102,0.84 [0.52-1.34],0.4640960855638454
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,19547,412,1.58 [1.24-2.00],0.0001895903151379
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,22688,201,2.25 [1.65-3.08],3.4557005088373304e-07
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9393,127,1.62 [1.07-2.45],0.0220651132251337
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9291,25,1.43 [0.56-3.61],0.4541031039976348
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9477,211,0.94 [0.68-1.29],0.6939524966868309
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9359,93,0.86 [0.52-1.40],0.5350422879993457
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9476,210,0.93 [0.67-1.28],0.638254957512717
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,22887,48,2.91 [1.56-5.45],0.0008224004838859
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",8235,154,1.13 [0.77-1.64],0.5331738502211405
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22911,3776,2.05 [1.90-2.21],4.648958508067581e-75
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",19229,94,1.35 [0.82-2.23],0.2439001022701495
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19592,179,4.24 [3.01-5.97],1.595427093278023e-16
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22600,41,0.94 [0.46-1.93],0.8630747003142053
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Urethral stricture,19278,271,1.08 [0.81-1.44],0.5933786345134597
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22956,397,0.81 [0.64-1.03],0.0860381204525848
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9301,35,0.62 [0.28-1.36],0.2345827338837998
